58.7 F
New York
Sunday, October 2, 2022

Date:

Share:

Developments in Gene Therapy for Ocular Diseases

Related Articles

London, United Kingdom, September 01, 2022 –(PR.com)– The Ophthalmic drugs industry continues to expand year on year, with an ageing population there is continual demand for advancements in ophthalmic treatments. This year’s Ophthalmic Drugs Conference will have a key focus on gene therapy and artificial intelligence with developments on the latest drug pipelines and clinical trials.

The conference will convene on 21 – 22 November 2022 in London, UK, this year attendees will hear from industry giants about the developments being made in the ophthalmics and gene therapy field.

Interested parties can register at http://www.ophthlamicdrugs.com/PR2PRCOM.

– Register by 30 September to save £100.
The 5th annual conference will have a more in-depth discussion about the Developments in Gene Therapy for Ocular Diseases, with presentations and keynote speakers.

Use of Antisense Oligonucleotides for the Treatment of Inherited Retinal…

Read more…

Popular Articles